A cheap antidepressant is showing promise treating COVID-19 in high-risk adults
Results from tests of the drug fluvoxamine published in Lancet Global Health this week were so strong that independent experts recommended stopping the study early because the results were clear.
Read more on NPR
Thursday, 28 October 2021
A cheap antidepressant is showing promise treating COVID-19 in high-risk adults
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.